CD40LG and neoplasm: Although breakdown of tolerance mechanisms in a tumor draining lymph node and entry into the GC, as seen in SLE, could provide an avenue for clonal redemption, this is unlikely to be the case as the tumor-reactive antibodies from the above studies were predominantly IgM, had little evidence of SHM, and increased mutations actually resulted in decreased tumor binding.